Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
Sign Up to like & getrecommendations! Published in 2020 at "Lipids in Health and Disease"
DOI: 10.1186/s12944-020-01406-4
Abstract: Background Reduction in elevated serum cholesterol concentrations is important in the management of individuals at risk of atherosclerotic cardiovascular disease (ASCVD), such as myocardial infarction and thrombotic stroke. Although HMGCoA reductase inhibitors (“statins”) are frequently… read more here.
Keywords: cholesterol concentrations; ldl cholesterol; cholesterol; ursodeoxycholate budca ... See more keywords